Louise Heron discusses the challenges faced by transformative therapies in HTA submissions, and the need to change the way we plan for and demonstrate cost effectiveness and the value offering.
Watch the hideo here
About Louise and Adelphi Values:
Louise Heron is senior director at Adel phi Values PROVE, where she provides senior strategic input and leads teams on PROVE projects that optimise market access for new products and treatments. She also leads Adelphi’s Health Economic offering. Louise has extensive experience in leading and conducting landscaping and literature research projects and in developing impactful health economic models and payer funding tools to communicate product value to payers.
Adelphi Values – https://www.adelphivalues.com
Adelphi can help you plan ahead
If you’re wanting to identify, demonstrate, and communicate the transformational value of your therapy, consult with Adelphi’s truly multidisciplinary team.